SYK - Board Member At Stryker Exercises Options Worth $1.13M | Benzinga
Highlighted on February 6, it was unveiled in an SEC filing that Stryker, Board Member at Stryker (NYSE:SYK), executed a significant transaction involving the exercise of company stock options.
What Happened: Disclosed in a Form 4 filing on Tuesday with the U.S. Securities and Exchange Commission, Stryker, Board Member at Stryker, executed a strategic derivative sale. This involved exercising stock options for 4,355 shares of SYK, resulting in a transaction value of $1,125,440.
Currently, Stryker shares are trading down 0.06%, priced at $339.56 during Wednesday's morning. This values Stryker's 4,355 shares at $1,125,440.
Unveiling the Story Behind Stryker
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and spinal devices. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Just over one fourth of Stryker's total revenue currently comes from outside the United States.
Financial Insights: Stryker
Revenue Growth: Over the 3 months period, Stryker showcased positive performance, achieving a revenue growth rate of 18.46% as of ...